{"title":"妊娠阶段差异影响母体肺泡巨噬细胞功能和对SARS-CoV-2感染的免疫。","authors":"Alina Fokina, Lisabeth Pimenov-Reifeltshammer, Anastasiya Hladik, Karin Lakovits, Asma Farhat, Florian Deckert, Mariem Radhouani, Jessica Broesamlen, Fanzhe Meng, Riem Gawish, Sylvia Knapp","doi":"10.1016/j.mucimm.2026.100366","DOIUrl":null,"url":null,"abstract":"<div><div>Pregnancy comes with complex immune adaptations to support the specific needs of each pregnancy stage. Infections during pregnancy pose an additional challenge in keeping the fine balance between protective and detrimental immune activation. Whether mucosal immunity adapts to different pregnancy stages is poorly understood. Through detailed profiling of lung immune cells, we discovered a selective expansion of tissue-resident alveolar macrophages (TR-AMs) during late gestation. Using scRNA-seq we identified TR-AMs as the functionally most altered pulmonary immune cells that exhibited an anti-inflammatory transcriptional state, reduced cellular interactions and diminished responsiveness to viral ligands. This gestation-stage-specific adaptation shaped the response to SARS-CoV-2 infection. While early-stage pregnant animals showed an enhanced anti-viral response and accelerated viral clearance, late-stage pregnancy infection mirrored the dampened immune state of TR-AMs and prevented exaggerated lung tissue damage. We postulate that pulmonary immune adaptations in pregnancy augment defenses to protect fetal development in early stages, yet preserve maternal fitness required for parturition at later stages.</div></div>","PeriodicalId":18877,"journal":{"name":"Mucosal Immunology","volume":"19 4","pages":"Article 100366"},"PeriodicalIF":5.5000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pregnancy stages differentially impact maternal alveolar macrophages' function and immunity to SARS-CoV-2 infection\",\"authors\":\"Alina Fokina, Lisabeth Pimenov-Reifeltshammer, Anastasiya Hladik, Karin Lakovits, Asma Farhat, Florian Deckert, Mariem Radhouani, Jessica Broesamlen, Fanzhe Meng, Riem Gawish, Sylvia Knapp\",\"doi\":\"10.1016/j.mucimm.2026.100366\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pregnancy comes with complex immune adaptations to support the specific needs of each pregnancy stage. Infections during pregnancy pose an additional challenge in keeping the fine balance between protective and detrimental immune activation. Whether mucosal immunity adapts to different pregnancy stages is poorly understood. Through detailed profiling of lung immune cells, we discovered a selective expansion of tissue-resident alveolar macrophages (TR-AMs) during late gestation. Using scRNA-seq we identified TR-AMs as the functionally most altered pulmonary immune cells that exhibited an anti-inflammatory transcriptional state, reduced cellular interactions and diminished responsiveness to viral ligands. This gestation-stage-specific adaptation shaped the response to SARS-CoV-2 infection. While early-stage pregnant animals showed an enhanced anti-viral response and accelerated viral clearance, late-stage pregnancy infection mirrored the dampened immune state of TR-AMs and prevented exaggerated lung tissue damage. We postulate that pulmonary immune adaptations in pregnancy augment defenses to protect fetal development in early stages, yet preserve maternal fitness required for parturition at later stages.</div></div>\",\"PeriodicalId\":18877,\"journal\":{\"name\":\"Mucosal Immunology\",\"volume\":\"19 4\",\"pages\":\"Article 100366\"},\"PeriodicalIF\":5.5000,\"publicationDate\":\"2026-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Mucosal Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1933021926000681\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/6/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mucosal Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1933021926000681","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Pregnancy stages differentially impact maternal alveolar macrophages' function and immunity to SARS-CoV-2 infection
Pregnancy comes with complex immune adaptations to support the specific needs of each pregnancy stage. Infections during pregnancy pose an additional challenge in keeping the fine balance between protective and detrimental immune activation. Whether mucosal immunity adapts to different pregnancy stages is poorly understood. Through detailed profiling of lung immune cells, we discovered a selective expansion of tissue-resident alveolar macrophages (TR-AMs) during late gestation. Using scRNA-seq we identified TR-AMs as the functionally most altered pulmonary immune cells that exhibited an anti-inflammatory transcriptional state, reduced cellular interactions and diminished responsiveness to viral ligands. This gestation-stage-specific adaptation shaped the response to SARS-CoV-2 infection. While early-stage pregnant animals showed an enhanced anti-viral response and accelerated viral clearance, late-stage pregnancy infection mirrored the dampened immune state of TR-AMs and prevented exaggerated lung tissue damage. We postulate that pulmonary immune adaptations in pregnancy augment defenses to protect fetal development in early stages, yet preserve maternal fitness required for parturition at later stages.
期刊介绍:
Mucosal Immunology, the official publication of the Society of Mucosal Immunology (SMI), serves as a forum for both basic and clinical scientists to discuss immunity and inflammation involving mucosal tissues. It covers gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, and genitourinary immunology through original research articles, scholarly reviews, commentaries, editorials, and letters. The journal gives equal consideration to basic, translational, and clinical studies and also serves as a primary communication channel for the SMI governing board and its members, featuring society news, meeting announcements, policy discussions, and job/training opportunities advertisements.